Health Technology · Pharmaceuticals: Major · NSE: ZOTA · data 2026-10-09

Zota Health Care Ltd.

Health check: Weak (2.1/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,324.1

Market cap

₹4,011 cr

P/E

—

P/B

—

ROE

-16.1%

ROCE

-9.7%

Debt / equity

0.39

Dividend yield

0.08%

1-year return

-10.8%

52-week high

₹1,740

52-week low

₹1,022

Operating margin

-15.2%

Growth

Revenue (last 12 months)	₹609 cr
Net profit (last 12 months)	₹-103 cr
Sales growth, 3 years (yearly)	56.9%
Profit growth, 3 years (yearly)	—

Chart patterns

Double bottom — breakout (key level ₹1,236.1)

Similar companies

SMS Pharmaceuticals Limited (SMSPHARMA) · Gufic Biosciences Limited (GUFICBIO) · Aarti Drugs Limited (AARTIDRUGS) · Unichem Laboratories Limited (UNICHEMLAB) · Kwality Pharmaceuticals Ltd (KPL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ZOTA in NSE Scanner →